For best results when printing this announcement, please click on link below:
http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20231106:nGNE1KkMZS&default-theme=true
DXS INTERNATIONAL PLC
Notice of 2023 Annual General Meeting
The Board of DXS International plc (the “Company”), the AQSE Growth Market
quoted clinical decision support developer and supplier of clinical decision
support systems, confirms that its Annual General Meeting is scheduled to take
place on Thursday 30th November 2023 at Noon at the Pavilion Café, Tanshire
Park, Shackleford Road, Elstead, Surrey GU8 6LB.
For further information in relation to the AGM, shareholders should refer to
the Notice of Annual General Meeting and the AGM Letter which have been
despatched to shareholders. Copies of these documents, along with the
Company's Annual Report for the year ended 30 April 2023, are available for
download from the Company's website www.dxs-system.co.uk .
The Directors of DXS International plc accept responsibility for this
announcement
Enquiries:
David Immelman (Chief Executive) DXS International plc 01252 719800 david@dxs-systems.com
Suite 2, Second Floor Ash House, Tanshire Park Shackleford Road Elstead, Surrey GU8 6LB
www.dxs-systems.co.uk
Corporate Advisor
David Papworth City & Merchant 0207 101 7676
Corporate Broker
Hybridan LLP Claire Louise Noyce 020 3764 2341
Note to Editors:
DXS International presents up to date treatment guidelines and
recommendations, from Clinical Commissioning Groups and other trusted NHS
sources, to doctors, nurses and pharmacists in their workflow and during the
patient consultation. This effective clinical decision support ultimately
translates to improved healthcare outcomes delivered more cost effectively
which should significantly contribute towards the NHS achieving its projected
efficiency savings